The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...

A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic, were linked to a 33% lower risk of ...

A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, ...

Patients with type 2 diabetes, treated with GLP-1 receptor agonists, show a decreased risk of being diagnosed with ...

Texas hairstylist Tim Bo Mack opened up to PEOPLE about his years-long struggle to lose weight. He finally found success ...

Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival ...

Caution is needed until the harms are better understood Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as a promising treatment for obesity and diabetes. Over the past few years, ...

In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

With its new serum, the medical grade skin care brand is targeting laxity, which many weight loss drug users experience.

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...